Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningits vaccine (MenAfriVacTM) : a randomized controlled trial
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2718819
Author(s) Ateudjieu, Jerome; Stoll, Beat; Nguefack-Tsague, Georges; Tchangou, Christoph; Genton, Blaise
Author(s) at UniBasel Genton, Blaise
Year 2014
Title Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningits vaccine (MenAfriVacTM) : a randomized controlled trial
Journal Vaccine : the official journal of the International Society for Vaccines
Volume 32
Number 43
Pages / Article-Number 5662-5668
Keywords SMS, supervision, AEFI surveillance, Immunization campaign, Meningitis vaccine, MenAfriVac (TM), Cameroon
Abstract To ensure vaccines safety, given the weaknesses of the national pharmacovigilance system in Cameroon, there is a need to identify effective interventions that can contribute to improving AEFI reporting.; To assess the effect of: (i) sending weekly SMS, or (ii) weekly supervisory visits on AEFI reporting rate during a meningitis immunization campaign conducted in Cameroon in 2012 using the meningitis A conjugate vaccine (MenAfriVac™).; Health facilities that met the inclusion criteria were randomly assigned to receive: (i) a weekly standardized SMS, (ii) a weekly standardized supervisory visits or (iii) no intervention. The primary outcome was the reported AEFI incidence rate from week 5 to 8 after the immunization campaign. Poisson regression model was used to estimate the effect of interventions after adjusting for health region, type of health facility, type and position of health workers as well as the cumulative number of AEFI reported from weeks 1 to 4.; A total of 348 (77.2%) of 451 health facility were included, and 116 assigned to each of three groups. The incidence rate of reported AEFI per 100 health facility per week was 20.0 (15.9-24.1) in the SMS group, 40.2 (34.4-46.0) in supervision group and 13.6 (10.1-16.9) in the control group. Supervision led to a significant increase of AEFI reporting rate compared to SMS [adjusted RR=2.1 (1.6-2.7); p>0.001] and control [RR=2.8(2.1-3.7); p>0.001)] groups. The effect of SMS led to some increase in AEFI reporting rate compared to the control group, but the difference was not statistically significant [RR=1.4(0.8-1.6); p=0.07)].; Supervision was more effective than SMS or routine surveillance in improving AEFI reporting rate. It should be part of any AEFI surveillance system. SMS could be useful in improving AEFI reporting rates but strategies need to be found to improve its effectiveness, and thus maximize its benefits.
Publisher Elsevier ; [Online:] Amsterdam
ISSN/ISBN 0264-410X
edoc-URL http://edoc.unibas.ch/dok/A6308392
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.vaccine.2014.08.012
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/25160064
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.324 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
15/05/2024